Invention Grant
US09388199B2 Pyrrolidine derivatives and their use as complement pathway modulators
有权
吡咯烷衍生物及其作为补体通路调节剂的用途
- Patent Title: Pyrrolidine derivatives and their use as complement pathway modulators
- Patent Title (中): 吡咯烷衍生物及其作为补体通路调节剂的用途
-
Application No.: US14409882Application Date: 2013-06-27
-
Publication No.: US09388199B2Publication Date: 2016-07-12
- Inventor: Eva Altmann , Ulrich Hommel , Edwige Liliane Jeanne Lorthiois , Jeurgen Klaus Maibaum , Nils Ostermann , Stefan Andreas Randl , Olivier Rogel , Anna Vulpetti
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent John B. Alexander
- International Application: PCT/IB2013/055294 WO 20130627
- International Announcement: WO2014/002053 WO 20140103
- Main IPC: C07D403/06
- IPC: C07D403/06 ; C07D403/14 ; C07D471/04 ; C07D403/12 ; C07F7/08
Abstract:
The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention and its therapeutic uses as complement pathway modulators for the treatment of ocular diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
- US20150166578A1 PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS Public/Granted day:2015-06-18
Information query
